# Tilray Brands, Inc. (TLRY)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TLRY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.16B | $ -149.05M | $ -114.08M | $ 398.40M | $ 1.61B |
| 2025 | $ 1.17B | $ -3.13B | $ -179.26M | $ 451.09M | $ 2.07B |
| 2024 | $ 1.13B | $ -349.30M | $ -84.80M | $ 527.75M | $ 4.69B |
| 2023 | $ 841.06M | $ -2.08B | $ -16.89M | $ 794.89M | $ 4.47B |
| 2022 | $ 841.11M | $ -658.80M | $ -295.79M | $ 786.36M | $ 5.55B |
| 2021 | $ 623.75M | $ -329.06M | $ -77.32M | $ 938.66M | $ 4.46B |
| 2020 | $ 546.17M | $ -643.30M | $ -372.80M | $ 511.83M | $ 131.44M |
| 2019 | $ 142.16M | $ -202.5K | $ -247.83M | $ 434.27M | $ 359.82M |
| 2018 | $ 31.21M | $ 12.67M | $ -88.31M | $ 54.73M | $ 35.22M |
| 2017 | $ 28.27M | $ 16.38M | $ -107.03M | $ 26.10M | $ 230.13M |
| 2016 | $ 7.53M | $ 551.9K | $ -4.33M | $ 0 | $ 20.61M |
| 2015 | $ 500.0K | $ -8.59M | $ -3.75M | $ 0 | $ 8.62M |
| 2014 | $ 0 | $ -154.9K | $ -34.2K | $ 0 | $ 138.2K |
| 2013 | $ 0 | $ -68.8K | $ -67.0K | $ 0 | $ 276.6K |
| 2012 | $ 0 | $ -124.1K | $ -57.1K | $ 0 | $ 319.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.25 |
| Liabilities / Eq | 0.45 |
| Current Ratio | 2.21 |

## Other views

- [Metrics](https://sponda.capital/en/TLRY.md)
- [Charts](https://sponda.capital/en/TLRY/charts.md)
- [Compare](https://sponda.capital/en/TLRY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.